These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 39217557)

  • 21. Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock Trial.
    Zeitouni M; Akin I; Desch S; Barthélémy O; Brugier D; Collet JP; de Waha-Thiele S; Greenwood JP; Guedeney P; Hage G; Hauguel-Moreau M; Huber K; Kerneis M; Noc M; Oldroyd KG; Piek JJ; Rouanet S; Savonitto S; Serpytis P; Silvain J; Stepinska J; Vicaut E; Vrints CJM; Windecker S; Zeymer U; Thiele H; Montalescot G;
    Chest; 2021 Apr; 159(4):1415-1425. PubMed ID: 33248059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization.
    Kim MC; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Cho SY; Rha SW; Bae JH; Cho JG; Park SJ;
    Int J Cardiol; 2011 Dec; 153(2):148-53. PubMed ID: 20843572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis.
    Cui K; Yin D; Zhu C; Yuan S; Wu S; Feng L; Dou K
    Front Cardiovasc Med; 2021; 8():695822. PubMed ID: 35071337
    [No Abstract]   [Full Text] [Related]  

  • 24. Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial.
    Tea V; Morelle JF; Gallet R; Cayla G; Lemesle G; Lhermusier T; Dillinger JG; Ducrocq G; Angouvant D; Cottin Y; Chamandi C; le Bras A; Steg PG; Montalescot G; Nelson AC; Simon T; Chatellier G; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2022 Oct; 115(10):496-504. PubMed ID: 36096979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.
    Sheth T; Pinilla-Echeverri N; Moreno R; Wang J; Wood DA; Storey RF; Mehran R; Bainey KR; Bossard M; Bangalore S; Schwalm JD; Velianou JL; Valettas N; Sibbald M; Rodés-Cabau J; Ducas J; Cohen EA; Bagai A; Rinfret S; Newby DE; Feldman L; Laster SB; Lang IM; Mills JD; Cairns JA; Mehta SR
    J Am Coll Cardiol; 2020 Sep; 76(11):1277-1286. PubMed ID: 32912441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Am J Cardiol; 2019 Aug; 124(3):334-342. PubMed ID: 31174834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete Versus Culprit-Only Revascularization in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
    Salih M; Ibrahim AM; Al-Akchar M; Bhattarai M; Koester C; Ayan M; Hafiz AM
    Cardiovasc Revasc Med; 2020 Dec; 21(12):1482-1488. PubMed ID: 32571757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
    Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G;
    Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in intravascular ultrasound findings in culprit lesions in infarct-related arteries between ST segment elevation myocardial infarction and non-ST segment elevation myocardial infarction.
    Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2010 Jul; 56(1):15-22. PubMed ID: 20350520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-Analysis Comparing Fractional Flow Reserve and Angiography-Guided Complete Revascularization of Nonculprit Artery for ST-Elevation Myocardial Infarction.
    Omar A; Senguttuvan NB; Ueyama H; Kuno T; Beerkens F; Rahim M; Elmariah H; Takagi H; Abdulkader RS; Yallanki HP; Pelliccia F; Mylavarapu DP; Claessen B; Pasceri V; Dangas G
    Am J Cardiol; 2022 Nov; 183():8-15. PubMed ID: 36115726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials.
    Bajraktari G; Bytyçi I; Henein MY; Alfonso F; Ahmed A; Jashari H; Bhatt DL
    Int J Cardiol Heart Vasc; 2020 Aug; 29():100549. PubMed ID: 32577495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culprit-Lesion-Only Versus Multivessel Revascularization Using Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis.
    Jo HS; Park JS; Sohn JW; Yoon JC; Sohn CW; Lee SH; Hong GR; Shin DG; Kim YJ; Jeong MH; Chae SC; Hur SH; Hong TJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi DH; Jang YS; Yoon JH; Chung WS; Seung KB; Park SJ
    Korean Circ J; 2011 Dec; 41(12):718-25. PubMed ID: 22259602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Levett JY; Windle SB; Filion KB; Cabaussel J; Eisenberg MJ
    Am J Cardiol; 2020 Nov; 135():40-49. PubMed ID: 32871112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel Disease.
    Hamza M; Mahmoud N; Elgendy IY
    J Interv Cardiol; 2016 Jun; 29(3):241-7. PubMed ID: 27245121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial.
    Biscaglia S; Guiducci V; Santarelli A; Amat Santos I; Fernandez-Aviles F; Lanzilotti V; Varbella F; Fileti L; Moreno R; Giannini F; Colaiori I; Menozzi M; Redondo A; Ruozzi M; Gutiérrez Ibañes E; Díez Gil JL; Maietti E; Biondi Zoccai G; Escaned J; Tebaldi M; Barbato E; Dudek D; Colombo A; Campo G
    Am Heart J; 2020 Nov; 229():100-109. PubMed ID: 32822656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2020 May; 301():54-64. PubMed ID: 32330691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction: Impact on treatment strategy and clinical outcome (FAST STEMI I study).
    Groenland FTW; Huang J; Scoccia A; Neleman T; Ziedses Des Plantes AC; Nuis RJ; den Dekker WK; Wilschut JM; Diletti R; Kardys I; Van Mieghem NM; Daemen J
    Int J Cardiol; 2023 Feb; 373():33-38. PubMed ID: 36436683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    Mehta SR; Wood DA; Storey RF; Mehran R; Bainey KR; Nguyen H; Meeks B; Di Pasquale G; López-Sendón J; Faxon DP; Mauri L; Rao SV; Feldman L; Steg PG; Avezum Á; Sheth T; Pinilla-Echeverri N; Moreno R; Campo G; Wrigley B; Kedev S; Sutton A; Oliver R; Rodés-Cabau J; Stanković G; Welsh R; Lavi S; Cantor WJ; Wang J; Nakamya J; Bangdiwala SI; Cairns JA;
    N Engl J Med; 2019 Oct; 381(15):1411-1421. PubMed ID: 31475795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction.
    Lang J; Wang C; Wang L; Zhang J; Hu Y; Sun H; Cong H; Liu Y
    Front Cardiovasc Med; 2022; 9():943323. PubMed ID: 36158792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.